LONDON (MMD Newswire) June 20, 2012 -- TCA Global Credit Master Fund L.P. (TCA) today announced it has entered into a $4 Million senior secured, revolving security with South Florida-based Medytox Solutions Inc (MMMS). Under the terms of the Agreement, TCA will supply the financing in a series of pre-negotiated tranches to the company.
The Secured Loan Note Facility has been provided through TCA Global Credit Master Fund ("TCA"), which seeks to provide financing to small, growing, private and listed companies. This loan will spur the company in its growth, as well as allow them to take advantage of additional opportunities in their sector.
With corporate headquarters based in West Palm Beach, FL USA, Medytox Solutions Inc.(www.medytoxsolutionsinc.com),"offers a complete, turn-key urine drug testing (UDT) program specializing in providing urine drug toxicology and comprehensive pain medication monitoring programs to physicians, clinics and rehabilitation facilities in the USA. The Medytox UDT program is utilized by physicians to identify and evaluate prescribed and/or non-prescribed drugs that when combined may cause adverse drug interactions dangerous to a patient's health."
TCA has provided financing to allow Medytox to take advantage of opportunities within their industry, specifically for the acquisition of additional "clinical laboratories" that are qualified and accredited to carry out the testing work required.
TCA Fund Management Group manages the TCA Global Credit Master Fund and acts as an advisor to countless small companies from its offices in the United States, United Kingdom and Australia. TCA is a short-duration, absolute return fund specializing in senior-secured lending to small, mainly listed companies in the U.S., Canada, Western Europe and Australia. The team has a level of domestic and cross-border expertise, long-standing experience and funding innovations, as is reflected in the number of transactions completed. This is a specialist business with an investment angle which fills an important finance gap in many leading markets. TCA provides a unique conduit for investors seeking steady, uncorrelated alpha-like returns in the SME universe.
For more information:
US +1 (786) 323-1650
UK +1 44 0 (207) 269 6880
This document is being furnished by TCA Fund Management Group the investment manager ("Manager") of TCA Global Credit Master Fund LP (the "Fund" "TCA") solely for use in connection with consideration of an investment in the Fund by prospective investors. The information contained herein does not constitute an offer to sell or the solicitation of an offer to purchase any security or investment product. Any such offer may only be made by means of delivery of an approved confidential offering memorandum and only in those jurisdictions where permitted by law. Prospective investors should inform themselves and take appropriate advice as to any applicable legal requirements and any applicable taxation and exchange control regulations in the countries of their citizenship, residence or domicile which might be relevant to the subscription, purchase, holding, exchange, redemption or disposal of any investments. The information contained herein does not take into account the particular investment objectives or financial circumstances of any specific person who may receive it. Before making an investment, prospective investors are advised to carefully review the offering memorandum with their advisers to determine whether the Fund is suitable. There is no guarantee that the investment objectives of the Fund will be achieved. No statement herein supersedes any statement to the contrary in the Fund's confidential offering emails. All information contained herein is confidential. This document may not be reproduced or copied without the prior written consent of the Manager. This document is subject to revision at any time and the Manager is not obligated to inform you of any changes made. The performance representations contained herein are not representations that such performance will continue in the future. There may be sharp differences between prior performance results; such performance should not be construed as an indicator of future performance. Performance information and/or results, unless otherwise indicated, are un-audited and their appearance reflects the estimated returns net of all expenses, including the management and performance fees similar to those of the Fund.
An investment in the Fund is speculative and involves a high degree of risk. Opportunities for withdrawal and transferability of interests are restricted. As a result, investors may not have access to capital except according to the terms of withdrawal specified within the confidential offering memorandum and other related documents. With respect to the present document and/or its accessories, the Manager makes no warranty or representation, whether express or implied, and assumes no legal liability for the accuracy, completeness or usefulness of any information disclosed. In addition to exposure to adverse market conditions, investments may also be exposed to changes in regulations, change in providers of capital and other service providers. The Manager does not accept any responsibility or liability whatsoever caused by any action taken in reliance upon information herein. The Fund and its General Partner (the "Manager" of the Fund) are registered and regulated by the Cayman Islands Monetary Authority (CIMA); regulated by the Securities and Exchange Commission (SEC). These interests will be offered and sold only to "Accredited Investors" as such terms are defined under federal securities laws.
This information may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). The Manager claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts.
Specific forward-looking statements could be in reference/ implication, but not limited to/of: impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties.